HS 3006-93-20-00 – Sugar based
Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026
Pharmaceutical goods specified in Note 4 to this Chapter. › Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses › Sugar based
- MFN duty rate
- 9.5 %
- GST
- 5%
- Unit of measure
- KGM
Sugar based
Estimate duty & taxes · Get classification help
Preferential tariff rates
- New Zealand: 7%
- UST/CUSMA (US): Free
- Colombia: Free
- Australia: 7%
- Costa Rica (CRT): Free
- Ukraine: Free
- Jordan (JT): Free
- UK: Free
- CPTPP: Free
- CPTPP – United Kingdom (CPUKT): Free
- Iceland: Free
- Honduras (HNT): Free
- Korea: Free
- Norway (NT): Free
- Commonwealth Caribbean Countries Tariff (CCCT): Free
- Peru: Free
- MXT/CUSMA (Mexico): Free
- CETA: Free
- LDCT: Free
- Israel (CIAT): Free
- Chile: Free
- Panama (PAT): Free
- Switzerland–Liechtenstein (SLT): Free
- GPT: 5%
Preference requires qualifying origin and origin proof or certification.
Frequently asked questions
What is the MFN duty on Sugar based (HS 3006-93-20-00)?
The T2026-2 MFN rate for tariff item 3006.93.20 is 9.5%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.
What is the duty on HS 3006-93-20-00 from the US?
Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.
Which trade agreement rates apply to HS 3006-93-20-00?
New Zealand: 7%; UST/CUSMA (US): Free; Colombia: Free; Australia: 7%; Costa Rica (CRT): Free; Ukraine: Free; Jordan (JT): Free; UK: Free; CPTPP: Free; CPTPP – United Kingdom (CPUKT): Free; Iceland: Free; Honduras (HNT): Free; Korea: Free; Norway (NT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; Peru: Free; MXT/CUSMA (Mexico): Free; CETA: Free; LDCT: Free; Israel (CIAT): Free; Chile: Free; Panama (PAT): Free; Switzerland–Liechtenstein (SLT): Free; GPT: 5%. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.